BackReShape Lifesciences Overview

ReShape Lifesciences Other Liabilities

Track ReShape Lifesciences's other liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

ReShape Lifesciences Other Liabilities History

Loading

ReShape Lifesciences vs. peers: Other Liabilities Comparison

Loading

ReShape Lifesciences Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ReShape Lifesciences (RSLS) FAQ

ReShape Lifesciences posts a other liabilities of $0 as of March 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, ReShape Lifesciences's other liabilities was $0. The latest reading is $0 (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Other Liabilities is one piece of ReShape Lifesciences's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for RSLS's other liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; ReShape Lifesciences's other metric pages and overview cover the third.

Judging ReShape Lifesciences against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in other liabilities easier to interpret. Start with $0 here, then scan peer and history charts to see if the gap is persistent.